Notice of Public Hearing: November 13, 2017 - Board of Registration in Pharmacy

Notice is hereby given pursuant to M.G.L. c. 30A, § 2, that the Board of Registration in Pharmacy (Board) within the Department of Public Health (Department), will hold a public hearing on the Board's proposed new regulation at 247 CMR 17.00, Sterile Compounding.  The proposed regulation sets standards for sterile compounding practice, as mandated by M.G.L. c. 112, § 39G.

The public hearing will be held on Monday, November 13, 2017, at 10:00 am in Room 417A/B (4th Floor), 239 Causeway Street, Boston, Massachusetts 02114.  Hearing testimony may be presented orally or in writing; a written copy of any oral testimony will be requested.

The Department encourages all interested parties to submit written testimony electronically to the following address: Reg.Testimony@state.ma.us. Please submit electronic testimony as an

attached Word document or as text within the body of an email, with "BOP:  247 CMR 17.00" in the subject line.  All submissions must include the sender's full name and address.  The Department will post all electronic testimony that complies with these instructions on its website. Parties who are unable to submit electronic testimony should mail submissions to the Office of the General Counsel, Department of Public Health, 250 Washington Street, Boston, Massachusetts 02108.  All written testimony must be submitted by 5:00pm on Thursday, November 30, 2017.

A copy of the Notice of Public Hearing and the proposed amendments to Board regulations may be viewed on the Department's website or obtained from the Office of the General Counsel, at (617) 624-5220.